Retour sur lavenir.net
   BPOST 1.266 € (-1,09 %)     ONTEX GROUP 2.330 € (-0,43 %)     TUBIZE-FIN 176.400 € (-0,84 %)     AB INBEV 68.640 € (+0,91 %)     GBL 74.750 € (+0,95 %)     DEME GROUP 182.400 € (+0,55 %)     ARGENX SE 863.200 € (-0,71 %)     European Medical S 4.080 € (+2,00 %)     ACKERMANS V.HAAREN 273.800 € (-0,36 %)     FAGRON 21.750 € (+0,23 %)     BARCO 7.610 € (-4,82 %)     UCB 208.100 € (-1,05 %)     WDP 21.340 € (+0,38 %)     CMB.TECH 17.100 € (+1,79 %)     KBC 133.300 € (-0,82 %)     XIOR 26.150 € (+0,19 %)     WERELDHAVE BELGIUM 50.800 € (-0,39 %)     VAN DE VELDE 30.000 € (0,00 %)     D'IETEREN GROUP 176.000 € (-0,23 %)     BQUE NAT. BELGIQUE 369.000 € (-0,27 %)     MELEXIS 67.050 € (-1,18 %)     ELIA GROUP 118.300 € (-1,74 %)     HOME INVEST BE. 18.760 € (+0,43 %)     RECTICEL 12.640 € (+1,28 %)     KINEPOLIS GROUP 49.450 € (+2,70 %)     VIOHALCO 16.920 € (-0,47 %)     AEDIFICA 66.800 € (-0,52 %)     TITAN S.A. 52.950 € (-0,66 %)     ASCENCIO 53.100 € (-0,38 %)     UMICORE 23.180 € (+2,48 %)     SOFINA 259.000 € (+1,33 %)     VGP 78.900 € (+0,38 %)     SYENSQO 81.700 € (+1,68 %)     NYXOAH 1.440 € (+0,98 %)     CIE BOIS SAUVAGE 305.000 € (-0,97 %)     TESSENDERLO 21.750 € (0,00 %)     BIOTALYS 2.235 € (-4,08 %)     TINC 11.240 € (+0,54 %)     GIMV 45.250 € (-0,77 %)     AGEAS 74.650 € (-1,45 %)     SHURGARD 22.800 € (+2,01 %)     LOTUS BAKERIES 12 320.000 € (+1,15 %)     ONWARD MEDICAL 2.605 € (+4,20 %)     SOLVAY 26.520 € (+2,16 %)     IBA 15.520 € (+0,78 %)     AZELIS GROUP 12.160 € (+1,33 %)     PROXIMUS 6.255 € (-0,08 %)     CENERGY 23.460 € (-0,68 %)     COLRUYT 39.600 € (+0,56 %)     DECEUNINCK 2.380 € (0,00 %)     BEKAERT 39.000 € (+0,39 %)     EVS 28.800 € (-0,35 %)     KBC ANCORA 95.000 € (-0,73 %)     JENSEN-GROUP 74.600 € (-1,32 %)     EKOPAK 3.700 € (-1,33 %)     SIPEF 104.000 € (-1,14 %)     ECONOCOM GROUP 1.490 € (+1,02 %)     MONTEA 65.000 € (+0,46 %)     IMMOBEL 20.500 € (-2,38 %)     CAMPINE 190.000 € (+4,40 %)  
   VALEO 14.915 € (+3,00 %)     OSE IMMUNO 2.950 € (-3,53 %)     GENFIT 12.760 € (-6,04 %)     SANOFI 74.840 € (-1,12 %)     ADOCIA 3.930 € (-0,66 %)     KERING 250.300 € (+3,69 %)     HERMES INTL 1 456.500 € (-1,25 %)     AIRBUS 198.460 € (-0,10 %)     THALES 231.600 € (+0,04 %)     AIR LIQUIDE 172.540 € (+1,04 %)     WOLTERS KLUWER 67.820 € (-0,12 %)     ARCELORMITTAL SA 68.120 € (+0,86 %)     TOTALENERGIES 77.320 € (+0,03 %)     EXOSENS 58.550 € (+1,91 %)     MERSEN 39.100 € (+1,03 %)     ESSILORLUXOTTICA 150.700 € (+1,45 %)     PHILIPS KON 22.130 € (+0,09 %)     ORANGE 15.265 € (-0,23 %)     SOCIETE GENERALE 74.110 € (-1,28 %)     SHELL PLC 40.800 € (+0,59 %)     ASML HOLDING 1 526.600 € (+1,75 %)     PROSUS 36.475 € (+0,05 %)     EDP RENEWABLES 13.290 € (-0,97 %)     VALLOUREC 18.900 € (+0,19 %)     PUBLICIS GROUPE SA 99.380 € (-0,67 %)     DERICHEBOURG 9.020 € (+0,50 %)     V LANSCHOT KEMPEN 67.800 € (+0,44 %)     GETLINK SE 18.430 € (+0,16 %)     SOLOCAL GROUP 4.375 € (+2,46 %)     HAFFNER ENERGY 0.612 € (-8,38 %)     DBV TECHNOLOGIES 2.330 € (+0,17 %)     ADYEN 993.700 € (-0,67 %)     ABIVAX 97.950 € (0,00 %)     SAINT GOBAIN 74.140 € (-0,64 %)     UBISOFT ENTERTAIN 4.882 € (0,00 %)     MOTA ENGIL 5.035 € (+4,59 %)     VOLTALIA 5.120 € (-1,16 %)     STMICROELECTRONICS 45.475 € (-2,49 %)     ROCTOOL 1.350 € (-5,59 %)     APERAM 47.600 € (-1,08 %)     CARREFOUR 16.635 € (+2,24 %)     ING GROEP N.V. 32.175 € (+0,22 %)     VEOLIA ENVIRON. 31.720 € (-0,60 %)     GTT 220.400 € (+0,18 %)     ASM INTERNATIONAL 842.600 € (-2,27 %)     EUROFINS SCIENT. 71.000 € (-0,84 %)     ALTRI SGPS 4.700 € (+0,32 %)     VINCI 114.200 € (+0,53 %)     ELIS 23.540 € (+2,79 %)     RANDSTAD NV 38.060 € (+0,24 %)     RIBER 8.740 € (-7,81 %)     DSM FIRMENICH AG 93.380 € (-0,11 %)     GALP ENERGIA-NOM 20.960 € (+1,16 %)     SBM OFFSHORE 36.480 € (+0,61 %)     AHOLD DEL 31.410 € (+1,00 %)     DRONE VOLT 0.352 € (-6,03 %)     RUBIS 35.100 € (+3,66 %)     KPN KON 4.089 € (-0,22 %)     LVMH 430.650 € (-0,13 %)     BIOPHYTIS 0.072 € (+2,86 %)  
News Réglementées
08/09/2026 13:35

Quantinuum Finalizes $100 Million CHIPS R&D Award with U.S. Department of Commerce to Advance Trapped-Ion Quantum Computer Manufacturing in the US

EQS-News: Quantinuum / Key word(s): Financing/Contract
Quantinuum Finalizes $100 Million CHIPS R&D Award with U.S. Department of Commerce to Advance Trapped-Ion Quantum Computer Manufacturing in the US

08.09.2026 / 13:35 CET/CEST
The issuer is solely responsible for the content of this announcement.


  • The federal funding supports critical R&D and U.S. quantum semiconductor manufacturing capabilities needed to scale fault-tolerant trapped-ion quantum computing.
  • Company partnering with GlobalFoundries to fabricate next-gen ion traps and control electronics, and Monarch Quantum to develop and manufacture reliable lasers and optical components.  

WASHINGTON, Sept. 8, 2026 /PRNewswire/ -- Quantinuum (Nasdaq: QNT), a leading quantum computing company, today announced it has finalized an agreement with the U.S. Department of Commerce's CHIPS Research and Development Office for $100 million in federal funding deployed through the CHIPS and Science Act. The award, which follows a letter of intent announced in May, supports R&D and U.S. quantum semiconductor manufacturing capabilities needed to deploy large-scale, fault-tolerant trapped-ion quantum computers.

Quantinuum Logo

Quantinuum, which was the only company with a trapped-ion based architecture to be awarded CHIPS R&D funding, develops the world's most accurate commercial[1] computers with industry-leading error correction fidelity.[2] The company leverages established semiconductor manufacturing processes to help ensure reliability, repeatability, and scalability of the company's current and future quantum computers.

"This award is a validation of Quantinuum's leadership in trapped-ion quantum computing," said Dr. Rajeeb Hazra, President and CEO of Quantinuum. "Together with our domestic partners, we are building the technology and supply-chain foundation needed to scale fault-tolerant systems and strengthen America's leadership in this strategically important field."       

The award will support R&D that the company expects to help strengthen and diversify its supply chain, adding onshore partners GlobalFoundries and Monarch Quantum. GlobalFoundries will be one of several of Quantinuum's foundries enlisted to fabricate its next-generation ion traps and other electronics, specifically focused on using 300mm wafer technology; Monarch Quantum plans to develop and manufacture scalable, reliable lasers and optical components required for Quantinuum's trapped-ion systems.

"As quantum computing moves closer to commercial scale, manufacturing will be critical to unlocking its full potential," said Tim Breen, CEO of GlobalFoundries. "GlobalFoundries is proud to partner with Quantinuum to help scale their trapped-ion technology. By bringing our expertise in high-volume, differentiated semiconductor manufacturing, we're helping create a path to more scalable, reliable quantum hardware and advancing the next generation of American innovation."

"The road to large-scale, trapped-ion quantum computers relies on moving away from complex, sprawling optical setups to scalable, reliable integrated photonics engines," said Dr. Timothy Day, CEO of Monarch Quantum. "We are honored to expand our partnership with Quantinuum to advance their hardware roadmap and to help strengthen U.S. leadership in quantum computing manufacturing and supply chain resilience."

Together, these efforts are intended to reduce system complexity and improve component robustness, reliability, and reproducibility, ultimately supporting the continued scaling of trapped-ion quantum computers, while strengthening domestic capability across critical photonics and semiconductor manufacturing.

About Quantinuum

Quantinuum is a leading quantum computing company offering a full-stack platform designed to make quantum computing deployable in real-world environments. The company has commercially deployed multiple generations of trapped-ion based quantum systems built on the well-established QCCD architecture, which it has implemented with novel designs and capabilities to achieve the industry's highest accuracy levels based on average two-qubit gate fidelity.[3] Quantinuum has active engagements with market leaders across pharmaceuticals, material science, financial services, and government and industrial markets, as well as academic and research institutions globally. The company has a global workforce of over 800 employees, including top scientists and researchers. Quantinuum's headquarters is in Broomfield, Colorado, with additional facilities across the United States, United Kingdom, Germany, Japan, Qatar, and Singapore. For more information, please visit www.quantinuum.com.

Cautionary Statement Concerning Forward-Looking Statements

This press release contains certain statements that may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts. The words "anticipate," "assume," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "future," "will," "seek," "foreseeable," the negative version of these words, or similar terms and phrases are intended to identify forward-looking statements. Such statements are based on certain assumptions and assessments made by our management in light of their experience and their perception of historical trends, current economic and industry conditions, expected future developments and other factors they believe to be appropriate. The forward-looking statements included in this release are also subject to a number of material risks and uncertainties, including but not limited to economic, competitive, governmental, and technological factors affecting our operations, markets, products, services and prices. New factors emerge from time to time, and it is not possible for Quantinuum to predict all such factors. For additional information on these and other risks that could affect Quantinuum's forward-looking statements, see Quantinuum's risk factors discussed in its filings with the U.S. Securities and Exchange Commission, including its Quarterly Report on Form 10-Q for the period ended June 30, 2026, as such risk factors may be updated from time to time. Any forward-looking statement speaks only as of the date on which it is made, and, except as required by law, Quantinuum does not undertake any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

[1] Based on physical two-qubit gate fidelity as of December 31, 2025, according to the 2025 Ransford et al. study.
[2] As of February 25, 2026, according to the 2026 Dasu et al. study.
[3] As of December 31, 2025.

press@quantinuum.com 

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/quantinuum-finalizes-100-million-chips-rd-award-with-us-department-of-commerce-to-advance-trapped-ion-quantum-computer-manufacturing-in-the-us-302871703.html

rt.gif?NewsItemId=EN41147&Transmission_Id=202609080730PR_NEWS_EURO_ND__EN41147&DateId=20260908


08.09.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2395882  08.09.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière